Blum Robert I 4

What Happened
Robert I. Blum, President & CEO and a director of CYTOKINETICS (CYTK), disposed of 7,500 shares on July 1, 2026. The shares were sold at $84.92 per share for a total transaction value of approximately $636,900. This was a sale (not a purchase); sales by insiders can be routine and do not necessarily indicate a change in company outlook.

Key Details

• Transaction date: 2026-07-01; filing date: 2026-07-02 (filed within normal reporting window).
• Shares sold: 7,500 at $84.92 per share; total proceeds ≈ $636,900.
• Transaction type: Sale (open-market or private sale as described in the filing).
• Shares owned after transaction: Not specified in the information provided.
• Footnotes: F1 — shares held by The Bridget Blum 2003 Irrevocable Trust; F2 — shares held by The Brittany Blum 2003 Irrevocable Trust.

Context

• This was a straightforward sale of existing shares rather than an option exercise, gift, or award.
• Insider sales are common for diversification, personal liquidity, or trust/account management; they are not by themselves proof of company prospects.